Celsius (NASDAQ:CELH) Price Target Lowered to $47.00 at Piper Sandler

Celsius (NASDAQ:CELH) had its price target cut by investment analysts at Piper Sandler from $50.00 to $47.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Piper Sandler’s target price would indicate a potential upside of 43.29% from the stock’s previous close.

Other analysts have also recently issued reports about the company. Stifel Nicolaus dropped their price target on Celsius from $61.00 to $51.00 and set a “buy” rating on the stock in a research report on Thursday, September 5th. Wedbush cut their target price on Celsius from $85.00 to $83.00 and set an “outperform” rating on the stock in a research note on Wednesday, June 12th. UBS Group reduced their price target on shares of Celsius from $70.00 to $64.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. B. Riley dropped their price objective on shares of Celsius from $80.00 to $73.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Finally, Maxim Group dropped their price target on shares of Celsius from $65.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, September 5th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $57.43.

Celsius Price Performance

Celsius stock opened at $32.80 on Tuesday. The company has a market cap of $7.65 billion, a PE ratio of 36.04, a P/E/G ratio of 2.46 and a beta of 1.85. Celsius has a 12 month low of $31.55 and a 12 month high of $99.62. The company has a fifty day moving average price of $39.99 and a two-hundred day moving average price of $63.21.

Celsius (NASDAQ:CELH) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. The business had revenue of $402.00 million during the quarter, compared to the consensus estimate of $391.07 million. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The company’s revenue for the quarter was up 23.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.17 EPS. Equities research analysts anticipate that Celsius will post 0.83 earnings per share for the current year.

Insider Buying and Selling

In other Celsius news, CEO John Fieldly sold 74,847 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the completion of the transaction, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.20% of the stock is owned by corporate insiders.

Institutional Trading of Celsius

A number of large investors have recently added to or reduced their stakes in the business. FinTrust Capital Advisors LLC acquired a new stake in shares of Celsius during the 1st quarter valued at $25,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Celsius by 3,116.7% during the first quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock valued at $32,000 after purchasing an additional 374 shares during the last quarter. Rise Advisors LLC boosted its position in shares of Celsius by 1,370.0% in the 1st quarter. Rise Advisors LLC now owns 441 shares of the company’s stock valued at $37,000 after purchasing an additional 411 shares during the period. Transcendent Capital Group LLC purchased a new position in Celsius in the 4th quarter worth about $25,000. Finally, Beacon Capital Management LLC acquired a new stake in Celsius during the 1st quarter worth about $40,000. 60.95% of the stock is currently owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.